Matinas BioPharma
Matinas is a biopharmaceutical company that focuses on cochleate delivery technology for the development of anti-infectives for rare diseases.
Business Model:
Revenue: $2.1M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Matinas BioPharma Information
Geographic Data
Address: 1545 Route 206 South
City: Bedminster
State: NJ
Zip: 07921
Country: US
Financial Info
Stage:
grant
Raised Last:
$4M
Raised Total:$48M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Matinas is a biopharmaceutical company that focuses on cochleate delivery technology for the development of anti-infectives for rare diseases.
Contact Phone:
+19084431860
Contact Email:
Matinas BioPharma went public on 8/1/2014 on the NYSE
Listed Exchange:
NYSE
IPO Date:
8/1/2014
Ticker Symbol:
MTNB
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2017 | Unattributed | $15.5M | 7/2016 | Equity | $4.4M | 8/2013 | Unattributed | $15M |
Aegis Capital Corp. |
11/2020 | Grant | $3.8M | 9/2016 | Equity | $8M |
Aegis Capital Corporation |
8/2016 | Post-IPO Equity | $4.4M | 4/2015 | Post-IPO Equity | $10M | 8/2013 | Venture Round | $7.6M | 5/2013 | Venture Round | 1 | $33M |
SternAegis SternAegis |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 1/2015 | Aquarius Biotechnologies |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
